Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

416 ARTÍCULOS , VIENDO DEL 361 AL 375

An elderly patient with Alzheimer's disease, normal pressure hydrocephalus and traumatic brain injury: presented with behavioral symptoms similar to behavioral variant frontotemporal dementia

Ates Bulut E, Karabay N, Soysal P, Isik AT.

Int J Neurosci. 2019 Jun;129(6):623-626. doi: 10.1080/00207454.2018.1552690. Epub 2018 Dec 21.

Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease

Cohen AD, Landau SM, Snitz BE, Klunk WE, Blennow K, Zetterberg H.

Mol Cell Neurosci. 2019 Jun;97:3-17. doi: 10.1016/j.mcn.2018.12.004. Epub 2018 Dec 8.

Genetic influences on white matter and metabolism abnormal change in Alzheimer's disease: Meta-analysis for neuroimaging research on presenilin 1 mutation

Gu X, Chu T, Liu L, Han X.

Clin Neurol Neurosurg. 2019 Feb;177:47-53. doi: 10.1016/j.clineuro.2018.12.016. Epub 2018 Dec 26.

Diet and biomarkers of Alzheimer's disease: a systematic review and meta-analysis

Hill E, Goodwill AM, Gorelik A, Szoeke C.

Neurobiol Aging. 2019 Apr;76:45-52. doi: 10.1016/j.neurobiolaging.2018.12.008. Epub 2018 Dec 27.

Value of testosterone in saliva in the diagnosis of Alzheimer's disease

de la Rubia Ortí JE, García-Pardo MP, Rochina MJ.

Med Clin (Barc). 2019 Jan 18;152(2):75-76. doi: 10.1016/j.medcli.2018.03.006. Epub 2018 Apr 25.

Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study

Andre L, Gallini A, Montastruc F, Coley N, Montastruc JL, Vellas B, Andrieu S, Gardette V; MAPT/DSA study group.

Br J Clin Pharmacol. 2019 Jan;85(1):71-99. doi: 10.1111/bcp.13734. Epub 2018 Oct 17.

Spectral-Domain OCT Measurements in Alzheimer's Disease: A Systematic Review and Meta-analysis

Chan VTT, Sun Z, Tang S, Chen LJ, Wong A, Tham CC, Wong TY, Chen C, Ikram MK, Whitson HE, Lad EM, Mok VCT, Cheung CY.

Ophthalmology. 2019 Apr;126(4):497-510. doi: 10.1016/j.ophtha.2018.08.009. Epub 2018 Aug 13.

Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment

Chandra A, Dervenoulas G, Politis M; Alzheimer’s Disease Neuroimaging Initiative.

J Neurol. 2019 Jun;266(6):1293-1302. doi: 10.1007/s00415-018-9016-3. Epub 2018 Aug 17.

Bidirectional relationship between caregiver burden and neuropsychiatric symptoms in patients with Alzheimer's disease: A narrative review

Isik AT, Soysal P, Solmi M, Veronese N.

Int J Geriatr Psychiatry. 2019 Sep;34(9):1326-1334. doi: 10.1002/gps.4965. Epub 2018 Sep 10.

Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology

Costa C, Romoli M, Liguori C, Farotti L, Eusebi P, Bedetti C, Siliquini S, Cesarini EN, Romigi A, Mercuri NB, Parnetti L, Calabresi P.

Neurobiol Aging. 2019 Jan;73:61-67. doi: 10.1016/j.neurobiolaging.2018.09.006. Epub 2018 Sep 18.

AMYPAD Diagnostic and Patient Management Study: Rationale and design

Frisoni GB, Barkhof F, Altomare D, Berkhof J, Boccardi M, Canzoneri E, Collij L, Drzezga A, Farrar G, Garibotto V, Gismondi R, Gispert JD, Jessen F, Kivipelto M, Lopes Alves I, Molinuevo JL, Nordberg A, Payoux P, Ritchie C, Savicheva I, Scheltens P, Schmidt ME, Schott JM, Stephens A, van Berckel B, Vellas B, Walker Z, Raffa N.

Alzheimers Dement. 2019 Mar;15(3):388-399. doi: 10.1016/j.jalz.2018.09.003. Epub 2018 Oct 16.

Subjective cognitive decline: preclinical manifestation of Alzheimer's disease

Lin Y, Shan PY, Jiang WJ, Sheng C, Ma L.

Neurol Sci. 2019 Jan;40(1):41-49. doi: 10.1007/s10072-018-3620-y. Epub 2018 Nov 5.

Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies

Boyle PA, Yu L, Leurgans SE, Wilson RS, Brookmeyer R, Schneider JA, Bennett DA.

Ann Neurol. 2019 Jan;85(1):114-124. doi: 10.1002/ana.25380. Epub 2018 Dec 19.

Is the Montreal Cognitive Assessment (MoCA) screening superior to the Mini-Mental State Examination (MMSE) in the detection of mild cognitive impairment (MCI) and Alzheimer's Disease (AD) in the elderly?

Pinto TCC, Machado L, Bulgacov TM, Rodrigues-Júnior AL, Costa MLG, Ximenes RCC, Sougey EB.

Int Psychogeriatr. 2019 Apr;31(4):491-504. doi: 10.1017/S1041610218001370. Epub 2018 Nov 14.

Targeting hippocampal adult neurogenesis using transcription factors to reduce Alzheimer's disease-associated memory impairments

Dard RF, Dahan L, Rampon C.

Hippocampus. 2019 Jul;29(7):579-586. doi: 10.1002/hipo.23052. Epub 2018 Nov 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias